Literature DB >> 1711478

Schistosoma mansoni: ingestion of dextrans, serum albumin, and IgG by schistosomula.

M W Bennett1, J P Caulfield.   

Abstract

Schistosomula of Schistosoma mansoni develop the ability to ingest and digest red blood cells after the fourth day post-transformation. Here, we have used fluorescently-labeled dextrans and two plasma proteins, albumin and IgG, to test whether day-old schistosomula can ingest and process macromolecules prior to the time that they eat red cells. Worms ingested dextrans of molecular weights 4,000, 70,000 and 2 x 10(6) in a time- and concentration-dependent manner. The dextran remained in the cecal lumen for up to 2 days after feeding. Parasites ingested both fluorescein-conjugated bovine serum albumin and rabbit IgG, but neither of these proteins remained confined to the cecum over time. Instead, fluorescence redistributed to the acetabular glands within a few hours. Thin-layer chromatography indicated that schistosomula degraded fluorescein-conjugated albumin to fluorescein-conjugated peptides approximately 10-15 amino acids long. The volume of the cecum was estimated to be 2431 microns 3 and the surface area 299 microns 2. These results demonstrate that larval schistosomes can ingest both proteins and complex carbohydrates shortly after transformation, before they can ingest red cells. Further, the gut apparently releases proteases that cleave plasma proteins, but not saccharidases that cleave dextran.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711478     DOI: 10.1016/0014-4894(91)90007-j

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  5 in total

1.  Derivatives of biarylalkyl carboxylic acid induce pleiotropic phenotypes in adult Schistosoma mansoni in vitro.

Authors:  Ariane S Blohm; Patrick Mäder; Thomas Quack; Zhigang Lu; Steffen Hahnel; Martin Schlitzer; Christoph G Grevelding
Journal:  Parasitol Res       Date:  2016-05-26       Impact factor: 2.289

2.  New perspectives on host-parasite interplay by comparative transcriptomic and proteomic analyses of Schistosoma japonicum.

Authors:  Feng Liu; Jiong Lu; Wei Hu; Sheng-Yue Wang; Shu-Jian Cui; Ming Chi; Qing Yan; Xin-Rong Wang; Huai-Dong Song; Xue-Nian Xu; Ju-Jun Wang; Xiang-Lin Zhang; Xin Zhang; Zhi-Qin Wang; Chun-Liang Xue; Paul J Brindley; Donald P McManus; Peng-Yuan Yang; Zheng Feng; Zhu Chen; Ze-Guang Han
Journal:  PLoS Pathog       Date:  2006-04-14       Impact factor: 6.823

3.  Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib.

Authors:  Svenja Beckmann; Thavy Long; Christina Scheld; Rudolf Geyer; Conor R Caffrey; Christoph G Grevelding
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-07       Impact factor: 4.077

4.  Predictions of novel Schistosoma mansoni - human protein interactions consistent with experimental data.

Authors:  J White Bear; Thavy Long; Danielle Skinner; James H McKerrow
Journal:  Sci Rep       Date:  2018-08-30       Impact factor: 4.379

5.  A novel cell-free method to culture Schistosoma mansoni from cercariae to juvenile worm stages for in vitro drug testing.

Authors:  Sören Frahm; Anisuzzaman Anisuzzaman; Ulrich Fabien Prodjinotho; Nermina Vejzagić; Admar Verschoor; Clarissa Prazeres da Costa
Journal:  PLoS Negl Trop Dis       Date:  2019-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.